Haisco Pharmaceutical Group Co., Ltd. (SHE: 002653)
China
· Delayed Price · Currency is CNY 34.06
-0.94 (-2.69%)
Nov 13, 2024, 3:04 PM CST
Haisco Pharmaceutical Group Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 3,702 | 3,335 | 2,998 | 2,765 | 3,328 | 3,936 | Upgrade
|
| Other Revenue | 19.94 | 19.94 | 17.03 | 8.46 | 2.08 | 1.6 | Upgrade
|
| Revenue | 3,722 | 3,355 | 3,015 | 2,773 | 3,330 | 3,937 | Upgrade
|
| Revenue Growth (YoY) | 12.72% | 11.27% | 8.73% | -16.71% | -15.44% | 14.90% | Upgrade
|
| Cost of Revenue | 1,036 | 971.25 | 925.27 | 946.88 | 1,068 | 1,348 | Upgrade
|
| Gross Profit | 2,687 | 2,384 | 2,090 | 1,826 | 2,262 | 2,589 | Upgrade
|
| Selling, General & Admin | 1,643 | 1,521 | 1,464 | 1,331 | 1,586 | 1,972 | Upgrade
|
| Research & Development | 552.92 | 516.67 | 447.87 | 431.4 | 405.53 | 235.42 | Upgrade
|
| Other Operating Expenses | 108.24 | 50.54 | 35.82 | 26.28 | 42.69 | 57.83 | Upgrade
|
| Operating Expenses | 2,307 | 2,089 | 1,948 | 1,789 | 2,034 | 2,266 | Upgrade
|
| Operating Income | 380 | 295.01 | 141.57 | 37.6 | 228.35 | 323.01 | Upgrade
|
| Interest Expense | -39.05 | -42.28 | -50.91 | -27.16 | -27.29 | -24.15 | Upgrade
|
| Interest & Investment Income | 147.56 | 19.33 | 235.41 | 426.35 | 301.58 | 31.21 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.06 | -0.06 | 0.97 | -0.17 | -2.43 | 0.28 | Upgrade
|
| Other Non Operating Income (Expenses) | -17.92 | -0.63 | 1.13 | -1.1 | -7.1 | -9.59 | Upgrade
|
| EBT Excluding Unusual Items | 470.54 | 271.36 | 328.16 | 435.52 | 493.1 | 320.75 | Upgrade
|
| Gain (Loss) on Sale of Investments | -23.95 | -60.47 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 25.25 | -0.28 | -0 | -0.13 | 0.33 | -0.02 | Upgrade
|
| Asset Writedown | -65.32 | -13.02 | -0.84 | -0.62 | -18.79 | -0.17 | Upgrade
|
| Other Unusual Items | 180.94 | 104.94 | 39.3 | 75.97 | 214.8 | 225.86 | Upgrade
|
| Pretax Income | 587.46 | 302.52 | 366.61 | 510.74 | 689.45 | 546.42 | Upgrade
|
| Income Tax Expense | 41.07 | 6.96 | -25.1 | -6.84 | 88.25 | 71.56 | Upgrade
|
| Earnings From Continuing Operations | 546.39 | 295.56 | 391.71 | 517.58 | 601.2 | 474.85 | Upgrade
|
| Minority Interest in Earnings | -70.2 | -0.45 | -114.64 | -172.52 | 35.42 | 19.04 | Upgrade
|
| Net Income | 476.19 | 295.11 | 277.07 | 345.06 | 636.62 | 493.89 | Upgrade
|
| Net Income to Common | 476.19 | 295.11 | 277.07 | 345.06 | 636.62 | 493.89 | Upgrade
|
| Net Income Growth | 27.06% | 6.51% | -19.70% | -45.80% | 28.90% | 48.21% | Upgrade
|
| Shares Outstanding (Basic) | 1,102 | 1,093 | 1,066 | 1,078 | 1,079 | 1,074 | Upgrade
|
| Shares Outstanding (Diluted) | 1,102 | 1,093 | 1,066 | 1,078 | 1,079 | 1,074 | Upgrade
|
| Shares Change (YoY) | 1.13% | 2.57% | -1.17% | -0.07% | 0.50% | -0.12% | Upgrade
|
| EPS (Basic) | 0.43 | 0.27 | 0.26 | 0.32 | 0.59 | 0.46 | Upgrade
|
| EPS (Diluted) | 0.43 | 0.27 | 0.26 | 0.32 | 0.59 | 0.46 | Upgrade
|
| EPS Growth | 25.64% | 3.85% | -18.75% | -45.76% | 28.26% | 48.39% | Upgrade
|
| Free Cash Flow | 96.81 | 58.57 | -605.62 | -667.14 | -395.51 | 181.58 | Upgrade
|
| Free Cash Flow Per Share | 0.09 | 0.05 | -0.57 | -0.62 | -0.37 | 0.17 | Upgrade
|
| Dividend Per Share | 0.345 | 0.200 | - | 0.185 | 0.372 | 0.092 | Upgrade
|
| Dividend Growth | - | - | - | -50.22% | 304.35% | -51.58% | Upgrade
|
| Gross Margin | 72.17% | 71.05% | 69.31% | 65.86% | 67.93% | 65.76% | Upgrade
|
| Operating Margin | 10.21% | 8.79% | 4.69% | 1.36% | 6.86% | 8.20% | Upgrade
|
| Profit Margin | 12.79% | 8.80% | 9.19% | 12.44% | 19.12% | 12.54% | Upgrade
|
| Free Cash Flow Margin | 2.60% | 1.75% | -20.08% | -24.06% | -11.88% | 4.61% | Upgrade
|
| EBITDA | 615.33 | 504.81 | 317.33 | 183.93 | 332.93 | 410.94 | Upgrade
|
| EBITDA Margin | 16.53% | 15.05% | 10.52% | 6.63% | 10.00% | 10.44% | Upgrade
|
| D&A For EBITDA | 235.32 | 209.8 | 175.76 | 146.33 | 104.59 | 87.93 | Upgrade
|
| EBIT | 380 | 295.01 | 141.57 | 37.6 | 228.35 | 323.01 | Upgrade
|
| EBIT Margin | 10.21% | 8.79% | 4.69% | 1.36% | 6.86% | 8.20% | Upgrade
|
| Effective Tax Rate | 6.99% | 2.30% | - | - | 12.80% | 13.10% | Upgrade
|
| Revenue as Reported | 3,722 | 3,355 | 3,015 | 2,773 | 3,330 | 3,937 | Upgrade
|
| Advertising Expenses | - | - | - | 3.74 | 6.74 | 1.82 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.